FIELD: medicine, cardiology, clinical biochemistry and medicinal immunology.
SUBSTANCE: invention relates, in particular, to immunologic composition and set used in diagnosis of heart diseases by using human mitochondrial adenylate kinase isozymes. As a marker, methods involve using human mitochondrial adenylate kinase isozymes presenting in myocardium muscle cells. These markers provide carrying out the precise diagnosis of heart disease being more easily.
EFFECT: expanded assortment of agents used in diagnosis of heart diseases.
14 cl, 17 dwg, 5 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
PEPTIDE CONCATEMER INDUCING PRODUCTION OF ANTIBODY AGAINST APOLIPOPROTEIN B-100, VACCINE FOR OBESITY TREATMENT, METHOD FOR PREPARING CONCATEMER, POLYNUCLEOTIDE, EXPRESSING VECTOR | 2001 |
|
RU2313536C2 |
IMMUNOGENIC HYBRID POLYPEPTIDES AGAINST OBESITY AND COMPOSITION OF ANTI-OBESITY VACCINES, CONTAINING SAID POLYPEPTIDES | 2007 |
|
RU2418005C2 |
METHOD FOR LIABILITY TO DEVELOPMENT OF ATHEROSCLEROSIS IN MIDDLE-AGED MEN | 2020 |
|
RU2738975C1 |
METHOD OF DETERMINING CEREBRAL ISOFORM OF CREATINE PHOSPHOKINASE IN HUMAN BLOOD | 2015 |
|
RU2600165C1 |
PHARMACEUTICAL COMPOSITION, CONTAINING INDOLE COMPOUND | 2010 |
|
RU2557243C2 |
METHODS FOR DETECTING CARDIAC DISORDERS | 2008 |
|
RU2498309C2 |
METHOD FOR DETERMINING CREATIN KINASE MACROFORMS AND MB-MACROFORM IN HUMAN BLOOD SERUM | 2018 |
|
RU2679656C1 |
METHOD FOR EARLY DIAGNOSTICS OF INFECTIOUS-TOXIC CARDIOPATHY IN NEONATALS | 2001 |
|
RU2200322C2 |
METHOD OF DIAGNOSING CAUSE OF DEATH FROM CARDIO-VASCULAR DISEASES | 2010 |
|
RU2425637C2 |
ALPHA- AND GAMMA-MSH ANALOGUES | 2013 |
|
RU2668791C2 |
Authors
Dates
2005-10-27—Published
2000-08-10—Filed